Supplementary Figure S3 from Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S3 shows how Immunotherapy Response Score adds to tumor mutation burden and microsatellite instability status for anti-PD-(L)1 monotherapy clinical benefit
Authors: Benjamin J. Bulen, Nickolay A. Khazanov, Daniel H. Hovelson, Laura E. Lamb, Marc Matrana, Mark E. Burkard, Eddy Shih-Hsin Yang, William J. Edenfield, Elizabeth Claire Dees, Adedayo A. Onitilo, Gary L. Buchschacher, Alan M. Miller, Benjamin M. Parsons, Timothy R. Wassenaar, Jennifer M. Suga, Robert D. Siegel, William Irvin, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri, Gregory A. Masters, Sachdev Thomas, Malek M. Safa, Daniel M. Anderson, Jonathan Mowers, Anna C. Dusenbery, Stephanie Drewery, Komal Plouffe, Travis Reeder, Hana Vakil, Lynnae Patrias, Amanda Falzetta, Ryan Hamilton, Kat Kwiatkowski, D. Bryan Johnson, Daniel R. Rhodes, Scott A. Tomlins
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4385258601